Micronized Fenofibrate: A Viewpoint by Jean-Pierre Després

Author： Després J-P.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.2, Iss.2, 2002-02, pp. : 133-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The French Prime Minister Mr Jean-Pierre Raffarin has launched a major reform of the country's health insurance system

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 436, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Micronized Fenofibrate in Dyslipidemia: A Focus on Plasma High-Density Lipoprotein Cholesterol (HDL-C) Levels

By Sharpe M.   Ormrod D.   Jarvis B.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 2, 2002-02 ,pp. : 125-132

Adis International

Access to resources Recommend Favorite

Cetuximab: A Viewpoint by Jean-Luc Van Laethem

By Jean-Luc Van Laethem  

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 119-121

Adis International

Access to resources Recommend Favorite

Prolonged-Release Ciprofloxacin: A Viewpoint by Jean L. Fourcroy

By Fourcroy J.L.  

American Journal of Drug Delivery, Vol. 4, Iss. 2, 2006-01 ,pp. : 121-121

Adis International

Access to resources Recommend Favorite

Zoledronic Acid: A Viewpoint by Jean-Jacques Body

By Body J-J.  

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 806-806

Adis International

Access to resources Recommend Favorite